Home

Joshua Schafer

CIK 1945557 · CCO · last filed 2026-02-04

Joshua Schafer is a CCO who has filed 11 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing shows the insider sold $96.5K of ZVRA on Feb 4, 2026. Across all open-market trades the lifetime net is −$191.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $772.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$772.2K

Companies

2

Total Filings

11

Lifetime Open-Market Net

-$191.6K

Filer Profile

Reported Address
SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
ONE RESEARCH COURT, SUITE 450
ROCKVILLE, MD 20850
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZVRA CCO 62,278 $12.40 $772.2K -$191.6K 8 2026-02-04
ZEVRA THERAPEUTICS, INC. (KMPH) Delisted CCO & EVP, Bus. Development — $5.81 — $0 1 2023-01-11

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-04 ZVRA Sell (S) −10,500 -$96.5K EDGAR
2026-02-02 ZVRA Mixed +43,292 -$29.8K EDGAR
2026-01-30 ZVRA Notice (144) −13,875 -$122.9K EDGAR
2025-02-14 ZVRA Sell (S) −10,500 -$82.5K EDGAR
2025-02-13 ZVRA Notice (144) −10,500 -$81.1K EDGAR
2025-02-03 ZVRA Mixed +35,333 $0 EDGAR
2024-02-02 ZVRA Grant (A) — $0 EDGAR
2023-09-06 ZVRA Buy (P) +500 $2.6K EDGAR
2023-06-30 ZVRA Buy (P) +1,000 $5.4K EDGAR
2023-03-15 ZVRA Buy (P) +2,000 $9.2K EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.